Immune checkpoint blockade and transarterial chemoembolization in liver-limited hepatocellular carcinoma: new questions at the dawn of a new era
Crossref DOI link: https://doi.org/10.1136/jitc-2025-012658
Published Online: 2025-08-27
Published Print: 2025-08
Update policy: https://doi.org/10.1136/crossmarkpolicy
Dhyani, Aruj
Harding, James J https://orcid.org/0000-0002-7029-4310
License valid from 2025-08-27